Thermo Scientific AcroMetrix Coronavirus 2019 (COVID-19) RNA Control

In an effort to combat the recent coronavirus outbreak, Thermo Fisher Scientific has designed and developed the Thermo Scientific AcroMetrix Coronavirus 2019 (COVID-19) RNA Control as a synthetic RNA, non-infectious control to help labs validate and monitor COVID-19 molecular diagnostic tests. Taking FDA guidelines into account, the controls were carefully designed at two different concentrations: a low positive control and an ultralow positive control.

The control is prepared by formulating synthetic RNA transcripts that contain N, S, E and Orf1ab regions of SARS-CoV-2 (COVID-19) genome into a proprietary buffer. The RNA is ready for reverse transcription, PCR amplification and detection, as appropriate to the test. The kit contains two vials of SARS-CoV-2 specific RNA at the concentration that will result low positive and ultralow positive in most commonly used PCR-based COVID-19 nucleic acid testing methods.

The control is available globally as a Research Use Only (RUO) product and is not intended for clinical use.